Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey

通过商业实验室残留血清检测和社区调查对严重急性呼吸综合征冠状病毒2血清阳性率的估计值进行比较

阅读：1
作者：Bajema,Kristina L,Dahlgren,F Scott,Lim,Travis W,Bestul,Nicolette,Biggs,Holly M,Tate,Jacqueline E,Owusu,Claudio,Szablewski,Christine M,Drenzek,Cherie,Drobeniuc,Jan,Semenova,Vera,Li,Han,Browning,Peter,Desai,Rita,Epperson,Monica,Jia,Lily T,Thornburg,Natalie J,Edens,Chris,Fry,Alicia M,Hall,Aron J,Schiffer,Jarad,Havers,Fiona P
期刊：Clinical Infectious Diseases影响因子：7.300
时间：2021起止号：2021 Nov 2;73(9):e3120-e3123
doi：10.1093/cid/ciaa1804

Abstract

We compared severe acute respiratory syndrome coronavirus 2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April and May 2020 and found these 2 estimates to be similar (4.94% vs 3.18%). Compared with more representative surveys, commercial sera can provide an approximate measure of seroprevalence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。